Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III data support use of mannitol test to identify EIB and asthma in children

March 3, 2010

Dual IL-4/IL-13 receptor antagonist AER-003 reduces AHR in primates

March 3, 2010

Orchid Research Laboratories presents new PDE4 inhibitor OCI-2987

March 2, 2010

Phase III study supports once-daily dosing of darunavir/ritonavir in HIV-1 infection

March 2, 2010

Efficacy and safety results of ecallantide treatment for hereditary angioedema attacks

March 2, 2010

Enhanced-sensitivity Trofile assay and HIV V3-loop sequencing comparably predict maraviroc response

March 2, 2010

Fluticasone nasal spray ineffective in irritant rhinitis in pilot trial

March 1, 2010

C5A inhibits HIV-1 and HSV in preclinical studies

March 1, 2010

Vicriviroc does not meet primary endpoint in two phase III trials in HIV

March 1, 2010

QNL-111 shown to inhibit HIV-1 DNA integration

March 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...